In the rapidly evolving field of psychiatric genetics, a paradigm shift is underway. For decades, the search for the biological underpinnings of mental health disorders has been dominated by the hunt for "risk genes." However, as research in the All of Us Research Program suggests, DNA is only part of the story.
A recent study published in Human Genetics and Genomics Advances (HGG Advances), authored by Dr. Rachel Sharp, challenges the traditional reductionist approach to bipolar disorder. By integrating social determinants of health (SDOH) with polygenic risk scores, Dr. Sharp’s work provides a compelling argument: we cannot fully understand psychiatric illness without accounting for the lived environments in which people exist.
The Intersection of Biology and Lived Experience
The motivation for this research stems from a realization that clinical data often lacks the nuance of human experience. Dr. Rachel Sharp, who recently defended her thesis in the Neuroscience Curriculum at the University of North Carolina at Chapel Hill, entered the field of statistical genetics with a background in frontline behavioral health. Before her academic career, Sharp worked on an emergency room behavioral assessment team and served as a crisis counselor.
These experiences were formative. "It is impossible to separate a person’s psychological symptoms from their daily life," Sharp explains. "Most of the time, these illnesses don’t just appear out of nowhere; their onset and severity are deeply entangled with a person’s environment, financial stability, and support systems."
In the current landscape of psychiatric research, polygenic risk scores (PRS)—tools designed to estimate an individual’s genetic predisposition to a disease—often fall short. In curated research cohorts, these scores explain only a fraction of the disease liability. When applied to real-world biobanks, which contain more diverse and representative populations, their predictive power diminishes further. Sharp’s research seeks to close this gap by treating the environment not as background noise, but as a primary data point.
Chronology of a Paradigm Shift
The journey to this publication was marked by a deliberate departure from siloed research methods.
Phase 1: Identifying the Predictive Gap
Sharp noted that current genetic models often fail to account for why two individuals with similar genetic risk profiles experience vastly different health outcomes. The missing link, she hypothesized, was the "social risk burden"—the cumulative impact of environmental stressors, socioeconomic status, and systemic barriers to care.
Phase 2: Leveraging Big Data
The project utilized the All of Us Research Program, a massive, ongoing effort to gather longitudinal health data from a diverse cohort across the United States. Unlike traditional studies that might ignore environmental variables, All of Us was specifically designed to capture comprehensive social and environmental data. This allowed Sharp to layer complex social metrics over the genetic profiles of participants.
Phase 3: Interdisciplinary Synthesis
The research required a synthesis of diverse fields. Sharp acted as a bridge between the quantitative rigor of statistical genetics and the qualitative insights of sociology and clinical psychology. The final paper, "Considering social risk alongside genetic risk for bipolar disorder in the All of Us Research Program," represents the culmination of this interdisciplinary effort, pushing the boundaries of how phenotypic data is handled and interpreted.
Supporting Data: The Case for Social Determinants
The most striking finding in Sharp’s research is the relative weight of social versus genetic factors. In the study, individuals who possessed the lowest genetic risk for bipolar disorder but faced a high burden of social risk displayed prevalence rates of the disorder that were comparable to, or even exceeded, those of individuals with the highest genetic risk but low social burden.
This data suggests that social stressors—such as housing instability, food insecurity, and limited access to healthcare—are not merely secondary triggers; they are foundational drivers of psychiatric risk.
For the genetics community, these numbers provide a sobering reality check. They indicate that even if we were to decode every relevant genetic variant associated with bipolar disorder, our ability to predict disease would remain incomplete without a corresponding "social score."

The Ethical Imperative: Official Perspectives and Methodology
The research brings to the forefront the ethical challenges of working with biobank data. Dr. Sharp emphasizes the need for caution when interpreting diagnostic billing codes and survey scores.
"When you spend every day looking at diagnostic billing codes… you have to be intentional about centering the human experiences that shaped those records," she notes. A diagnostic code in a database might represent a clinical reality for one patient, but it could also reflect clinician bias or, conversely, the absence of a code might simply signify that a patient lacked the financial means to seek a formal diagnosis.
This awareness led to a more robust methodology. By accounting for the potential "noise" created by healthcare access disparities, the team was able to produce more accurate, nuanced findings. The study encourages researchers to view the absence of data as potentially meaningful—often a reflection of systemic inequity rather than biological health.
Implications for the Future of Human Genetics
The implications of this research are wide-reaching, both for clinical practice and for the future of genetic policy.
1. A Holistic Model of Disease
The human genetics community is beginning to acknowledge that "messiness" is an inherent feature of human cohorts. Unlike laboratory organisms, humans live in environments that cannot be standardized. Sharp’s work advocates for a model of genetics that accepts this complexity, moving away from the attempt to "hold the environment constant" and toward an approach that treats environmental context as a critical variable.
2. Redefining "Risk"
Sharp’s perspective is informed by recent advancements that challenge the definition of a "risk variant." She points to a notable study involving the Turkana people of Kenya, where genetic variants associated with cardiometabolic risk in urban environments were found to be protective in the group’s ancestral desert environment.
This reinforces her own findings: genetic variants do not have a single, fixed effect. Their impact on health is entirely contingent upon the environment. This realization could reshape how we develop personalized medicine, shifting the focus from simply identifying "bad" genes to understanding how specific genetic profiles interact with specific environmental stressors.
3. Policy and Clinical Translation
If social factors are as significant as genetic factors in the manifestation of bipolar disorder, then the clinical response must change. If we can identify high-risk social profiles, we can implement targeted community interventions—such as financial support, improved housing stability, or expanded mental health access—long before a full-blown crisis occurs. The research suggests that social policy is, in effect, health policy.
Conclusion: A More Human Science
Dr. Rachel Sharp’s work serves as a reminder that science is at its best when it remains grounded in the communities it serves. By bridging the gap between statistical genetics and the lived experiences of patients, she has provided a blueprint for a more equitable and accurate approach to psychiatric research.
"My multidisciplinary training helps me make connections across fields, question standard methodologies, and keep my research grounded in the communities it’s meant to serve," Sharp concludes. As the field of genetics continues to advance, the integration of social, environmental, and genetic data will likely become the gold standard. For those suffering from the burden of mental health conditions, this shift toward a more holistic, human-centered science offers not just better data, but the promise of more effective, compassionate, and meaningful interventions.
In the final analysis, the story of our genes cannot be written without the story of our lives. By finally including that chapter, the scientific community is taking a vital step toward a true understanding of human health.
